Lab-grown mini brains may predict which Alzheimer’s treatments will work

Miniature brain models grown from patients’ cells revealed striking differences in how Alzheimer’s-related tissue responds to an antidepressant. The organoids and the particles they release could eventually guide more personalized treatments and provide new clues for diagnosing the disease.

This story was reported by Healthy Aging News -- ScienceDaily. EUROPES curates Europe's most relevant coverage — read the full report at the original source.